NCT02697032View on ClinicalTrials.gov

FDHT PET and Bicalutamide in Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

November 25, 2019

Study Completion Date

November 25, 2019

Conditions
Breast Cancer
Interventions
DRUG

Bicalutamide

150mg

PROCEDURE

FDHT PET

PET scan

Trial Locations (1)

9713 GZ

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT02697032 - FDHT PET and Bicalutamide in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter